{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-045029","form_type":"8-K","ticker":null,"cik":"0001622879","company_name":"Medicine Man Technologies, Inc.","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.094236+00:00","generated_at":"2026-05-22T12:15:06.625671+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Chief Policy Officer Daniel Pabon departs Medicine Man Technologies; receives $250K severance","bullets":["Daniel Pabon terminated as Chief Policy and Regulatory Affairs Officer effective April 30, 2025.","Severance: $250,000 cash (12 months base salary) plus 12 months COBRA subsidy.","Equity vesting accelerated for options vesting May 3, 2025; exercise period extended to expiration.","Departure part of strategic restructuring to consolidate roles and eliminate redundancies."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-045029","json":"https://secwatch.observer/filing/0001104659-25-045029.json","markdown":"https://secwatch.observer/filing/0001104659-25-045029.md","text":"https://secwatch.observer/filing/0001104659-25-045029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1622879/000110465925045029/0001104659-25-045029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1622879/000110465925045029/tm2514177d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T12:15:06.625671+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e69f5a487a","claim":"Daniel Pabon was terminated as Chief Policy and Regulatory Affairs Officer at Medicine Man Technologies, Inc..","evidence_excerpt":"On May 2, 2025, Medicine Man Technologies, Inc. (the “Company”) and Daniel Pabon, the Company’s Chief Policy and Regulatory Affairs Officer, entered into a Separation Agreement and Release (“Separation Agreement”), pursuant to which Mr. Pabon’s employment with the Company terminated effective April 30, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1622879/000110465925045029/0001104659-25-045029-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Policy and Regulatory Affairs Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}